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Conclusion: Because molecular typing makes it possible to track the
dissemination of specific clones, it may facilitate the breaking down of
endemic transmission to the level of micro-epidemics.
IMoG2-311s multi-resistance an indicator of higher
transmissibility of nosocomial pathogens?
M. J. Struelens
Universite Libre de Bruxel/es, Hopital Erasme, Brussels, Belgium
A large number of molecular epidemiologic studies document the epidemic
spread of antibiotic-resistant clones of nosocomial pathogens within and
between hospitals. The pressure of intense antibiotic use in the hospital
patient population confers a selective advantage to resistant clones which are
more likely to survive and multiply to replace the antibiotic susceptible
commensal tlora. Examples ofepidemic antibiotic resistant clones associated
with large scale epidemics which can lead to a net excess of nosocomial
infection by that species include methicillin-resistant Staphylococcus aureus,
clindamycin-resistant Clostridium dijJicile, multi-drug resistant A&inetobacter
baumannii. Klebsiella pneumoniae. Enterobacter aerogenes and Burkholderia
cepacia. Less information is available regarding the hypothesis that successful
antibiotic resistant clones carry additional virulence determinants enhancing
their transmissibility and/or pathogenicity. This type ofassociation has been
found among epidemic types of Klebsiella pneumoniae, carrying large
plasmids encoding multi-drug resistance (extended spectrum beta-Iaeta-
mase, aminoglycoside modifying enzymes) aerobaerin and an adhesin
promoting colonization of intestinal epithelium. Likewise, a pandemic
electrophoretype 12 of Burkholderia cepacia associated with nosocomial
outbreaks in cystic fibrosis patients harbours a specific gene coding for the
cblA pilin subunit and a conserved IS element which may promote genomic
rearrangements involved in resistance or transmissibility. Whereas multi-
resistance is often an indicator of epidemicity for nosocomial pathogens,
more studies are needed to determine genetic and functional determinants of
enhanced transmissibility ofepidemic clones beyond the seleerive advantage
of resistance. Identification of such markers would be useful to predier the
epidemic potential ofclinical isolates and respond accordingly with infection
control measures.
IMoG2-SI What tools do we need to understand the
dynamics of hospital acquired infections in places like intensive
care units?
H:ajo Grund.tna.nn
Noltingham. United Kingdom University
Molecular typing provides infection control personnel with a wealth ofdata
pertaining to the population structure ofthe pathogens that are isolated from
patients. Since hospital epidemiologists are conventionally more interested
in the population of hosts than in that of the pathogens routine typing data
are usually not exploited to their fuJI potential. Using this data for the
analysis of time space interaction by genotype may lead to the identification
of miniclusters that occur above a certain level of expeerancy. A couple of
statistical tests can be employed to that end. Another way ofutilising typing
data introduces differential risk faeror analysis which may include some
classical case control or cohort approaches. In typically endemic situations i.e
in the absence of outbreaks, hidden transmission dynamics may thus be
revealed and the success ofpreventive measures may be predicted by simple
stochastic models.
5G03 - E5GNI
IMoG3-11 Diagnosis and prevention of surgical site infections:
Problems with definitions
R. C. Spencer
Public Health Laboratory, Bristol BS2 8HW. United Kingdom
Surveillance studies require careful planning with a clear protocol, but,
above all, they need accepted definitions. No single set ofdefinitions has been
universally adopted, although there is a generally agreed-upon group of
ideas or problems central to the issue. A variety ofdefinitions ofnosocomial
infections have been proposed and used in hospital surveiJlance studies. Some
reports have proposed very simple definitions, while others have produced
much more detailed ones. Even when epidemiologists, nurses and clinical
microbiologists have produced consensus definitions, some health-care
workers stiJl find problems in their interpretation. There is no doubting
that variations in defmitions can influence the recorded rate ofinfection and
without definitive definitions, comparisons between hospitals are mean-
ingless. Unfortunately many individual institutions modify these consensus
definitions to suit their own particular resident populations and doctor/
laboratory facilities and availability. Indeed, some authors recommend that
this should happen. Whichever defmitions are used, microbiological and
imaging findings should be used only to confirm clinical evidence of
infection. It is strongly recommended that aJl professional as.sociations of
those health-eare workers involved in the surveillance of nosocomial
infections should co-operate to develop standardised case definitions suitable
for routine use. A plea is made for simplicity and clarity. It remains essential
that such case defmitions for surveillance purposes ensure a high level of
sensitivity in order to allow the earliest detection of infective nosocomial
problems.
IMoG3-21 Nosocomial aspergillosis: Are there effective
measures for prevention
Patricia Munoz
Hospilal Gtneral Universilario "Gregorio Marmion". Madrid, Spain
Aspergillosis is the second most common nosocomial mycosis. Recommen-
dations to prevent aspergillosis in high-risk patients include the reduction of
environmental exposure and the recognition of predisposing faerors and
periods ofincreased risk The strict observation ofinfection control measures
(air quality, isolation of construction works) in centers with immunocom-
promised patients is essential. Environmental protection trying to insure that
the air of selected units is free from Aspergillus spores is the most important
step of prophylaxis, although it is not always possible. Constant environ-
mental surveillance is a difficult goal and exposure may occur at other sites of
the hospital or in the community. The prompt recognition ofnosocomia1
cases is also recommended. The reduction of predisposing factors in high-
risk patients may include the prevention and adequate management of
neutropenia and rejection episodes, the prevention of infections such as
CMV. HHV-6 or relapsing HCV and the judicious use of Immuno
suppressive therapy. Targeted surveillance cultures and primary prophylaxis
against invasive aspergillosis are not standard measures in solid organ
transplant recipients although they are more commouly used for neutro-
penic patients. The current lack of reliable preventive regimens against
aspergillosis and against emerging resistant fungal pathogens presents an
ongoing challenge. New antifungal agents, such as triazoles and new AMB
presentations. have proved to be u..,ful in some recent studies.
5G04 - EHP5G
IMoG4-1 [ Non-invasive tests for the diagnosis of Hellcobacter
pylori infection
H. Rautelin
Department ofBacteriology and Immunology, Haartman Institute, University of
Helsinki, and Helsinki U"iversity Central Hospital Laboratory Diagnostics,
Helsinki, Finland
Non-invasive (gastroscopy not needed) diagnosis of H. pylori infection
includes in practice detection of H. pylori antibodies, urea breath tests, and
a recently developed test detecting H. pylori antigen in stool. In the primary
diagnosis of H. pylori infection, non-invasive diagnostic methods may be
used solely in younger patients who are not endoscopied. Among patients
endoscopied, non-invasive diagnostic methods are useful in addition to
invasive tests. For instance in atrophic gastritis, invasive diagnostic methods,
and even urea breath test, may fail in showing H. pylori probably due to the
low number of bacteria present. However, elevated antibody titres of H.
pylori may still indicate the infection in these cases. In general, no single test is
optimal in the diagnosis of H. pylori infection but the best test(s) in each
clinical setting may be chosen if the advantages and restrictions of the
different tests are known. AJI diagnostic tests should be validated locaJly. As
the prevalence of H. pylori infection is rapidly decreasing in developed
coumries, the positive predictive value of the test might be very different
from that in a high prevalence population.
In contrast to biopsy-based tests, non-invasive diagnostic methods may
also be used for the foJlow-up oferadication therapy; urea breath test as early
as 4 weeks and quantitative serology 4-6 months after the therapy. If
serology is used for the foJlow-up, pre-treatmcm serum sample must be.
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IMoG4-3IAntimiaobial resistance in Helicobacter pylori. The
European scene
F. Megraud
Laboratoire de Bacteriologie, Hopital Pellegrin, Bordeaux, France
Antimicrobial r~istance is considered to be thc major risk factor for failure
of therapies aiming to eradicate Helicobacter pylori. In Europe. there is a great
diversity in the policies concerning the use ofantibiotics. This diversity may
be reflected in the resistance rate of H. pylori.
A large European survey conducted by Glupczynski et al. in 1997-98
involved 22 centers in 17 countries; 1.305 isolates were tested (mean no./
center: 59) using a standardized Etest methodology. While the global rate of
resistance to clarithromycin was 9.8% [95% Cl (8.3-11.5»), there were
important variations between the northern (4.5'Yo) and thesouthcrn (18.1 %)
parts of the continent, and between children and adult patients. For
metronidazole. the global rate of resistance was 33% [95% CI (30.5-
35.6») with no major regional differences. The drawback of this study. as
for many others, is that only referral centers wcre involved. with a risk of
recruitment bias. For this reason. we began an active survey in Francc where
a large number ofgastroentcrologists were asked to send one positive biopsy
on a given day. In 1997, the rate ofrcsistance to clarithromycin was 14%. and
to metronidazole 24% (N = 525 adults). It has not increased significantly
these last years. A similar survey, but only hospital based. was carried out in
Portugal in 1999. The rate ofresistance to clarithromycin was 11.6% and to
metronidazole 14.3% (N = 545). In northern and central Italy, 200 strains
obtained during a clinical trial in DU patients showed a resistance rate of
11.3% to clarithromycin and 14.7% to metronidazole.
Globally, a trend towards increased resistance can be observed for
macrolide resistance. While amoxicillin resistance seems uncommon, a
strain has been found in the Netherlands, and tolerant strains have been
reported in Italy. These results are arguments for setting up surveillance
systems in the different European countries.
5G06 - E5GAP
IMoG6-21 National antibiotic policies in different CEE
countries
V. Krcmery,Jr
School ofPublic Health, University of Tmava, Tmava, Slovakia; School of
Health Administration, University of Scranton, Scranton, PA, United States
ObjediVlK: Increasing consumption of antimicrobial agents and increasing
antibiotic resistance in Central Eastern Europe led to a concern of treat
Health Care antibiotics. Therefore most of 11 surveyed CEE countries
adopted after initial liberalization. all countries included both, national and
hospital based antibiotic policies, including antibiotic cauntees, National
Hospital ATB formularies, restricted prescribing, HMO/Hospital reserved
antibiotics.
Results: Similarities and differences in CEE countries (Slovak Republic,
Czech Republic, Hungary. Austria. Germany. Poland, Croatia. Slovenia,
etc.) are discussed as well as adherence to various guidelines and their impact
to ATB consumption. Four of 11 countries has centralized but 9 of 11
hospital based ATB policies. Numerous antimicrobials are restricted in 8 of
11 countries for hospital use. However, only 3 of 11 CEE countries restrict
ATB (e.g. qiunolones oOrd Generation CEF's) for GP use.
5G07 - E5GMD
ITuG7-31 Molecular detection of antibiotic resistance
R. Leclercq
Microbiology, CHU Caen, 14033 Caen cedex, France
A major research effort in clinical microbiology has been the development of
rapid methods for antimicrobial susceptibility testing. The genotypic
approach could offer interesting possibilities to detect antimicrobial resis-
tances since it is rapid and independent from breakpoint categorization
which differs from a country. to another one. DNA probes. including
oligonuclcotide probes, were first used for detection of resistance genes.
Nucleic acid-based amplification techniques have been developped which
improve sensitivity of detection and allows detection of resistance directly
from clinical samples. Recently developped methods. DNA chips. would
allow to use thousands of oligonucleotides in a single reaction. One possible
limitation of these techniques is the observation that not only acqnisition or
mutation ofstructural genes are responsible for resistance, but also regulation
ofgene expression. Also. false positive results are expected in the case ofsilent
genes detected by the genotypic techniques but not expressed.
Applications are mostly devclopped for resistances difficult to detect
phenotypically in rapidly growing bacteria. such as methicillin resistance
in staphylococci or glycopeptidc resistanec in enterococci. or resistance in
fastidious organisms. such as mycobacteria and Helicobacter pylori. In the
latter case. resistances can be detected by PCR done on bacterial DNA
extracted from gastric biopsy material.
Synergistic combination of genotypic and phenotypic techniques should
help to rule out inappropriate therapy. The genotypic approach could help
the physicians to prescribe antibiotics only to patients who need them.
Information provided by the genotypic techniques should help to evaluate
the extent of the resistance determinant pool in outbreaks.
5G10 - EWPARAB
ITuG10-1\ Taxonomy of new anaerobic bacteria
Hannele Jousimies-Somer
National Public Health Institute, Helsinki, Finland
As a result of 16S rRNA sequencing. major reorganizations among
anaerobic taxa are underway. The gram-negative pigmented Prevotella
now include 8 species. the latest being Pr. nigrescens, Pr. tannerae and Pr.
pallens, The nonpigmented former Mitsuokel/a dentalis and Hallella seregens
were renamed as one species, Prevotella dentalis. The bile-sensitive. oral Pr.
heparinolytica and Pr. zoogleoformans phylogene- tically cluster in B·fragilis-
group. Bacteroides tectum homology group 11 (zoonotic) are genotypically
identical with B. pyogtMs. The bile-resistant B. distasonis clusters with B.
forsythus among PorphyromOllas which currently include 11 pigmented and
one nonpigmented species: P. tatoniae; several new groups awaite inclusion.
Fusobacterium nucleatum currently has 5 subspecies and is very heterogenous;
(phylo)genetic analyses place F. periodonticum within F. nucleatum. F. varium
includes F. pseudonecrophorum. The bile-sensitive, former B. gracilis now are
Campylobaeter gracilis; the bile-resistant variants belog to a new genus
Sutterella as S. wadsworthensis. Capnocytophaga hemolytica, C. granulosa and
Leptotrichia sanquinegens are new species among the capnophilic taxa.
Desulfovibrio fairfieldensis is a new species among the Desulfovibrio and
Anaerobiospirillum thomasii a new spiral, motile organism.
The new Actinomycesspecies include two subspecies ofA. neuii, A. radingae
- A. turicensis complex. A. europaeus, A. slackii, A. graevenitzii and several
other species. A. pyoJlenes and A. bernardiae were recently transferred to the
genus Arcanobacterium. Actinomyces suis and Actinomyces-like organisms from
human origin were reclassified to a new genus ActillObaculum. The genus
Eubacterium sensu stricto is represented by E. limosum and the former E.
alactolyticum was reclassified in a new genus PseuJoramibacter as P. aladolyticus.
Eggerthella lellla was Eubacterium lentum; other new gram-positive genera
include Collinsella, Slackia, Crypto bacterium, Atopobium, Holdemania and
Filifactor. The genus Peptostreptococcus also harbors new species; P. harei, P.
ivorii and P. octavius. Finegoldia magnus and Micromonas micros are new
synonyms of P. magnus and P. micros, respectively.
ITuG10-31 Antibiotic susceptibility of Bacteroides fragllis in
Europe
E. Nagy
Dept. ofClinical Microbiology, Faculty of Medicine, University ofSzeged,
Hungary
Bacteroides fragilis is the most commonly isolated human pathogenic anae-
robic bacterium belonging in the Bacteroides genus. senso stricto. Antibiotic
resistance problems were reported most frequently for members of this
genus during past decades. often without discrimination of isolates on a
species level. Besides the reference agar-dilution method. the determination
of MICs by the Etest has become available for routine laboratories to
evaluate the resistance of clinical isolates of anaerobes more easily.
Antibiotic resistance due to beta-Iactamase activity is observed most
oftenamong B. fragilis and related species. A unique merallo-bera-lactamase
production of B. fragilis is responsible for the resistance of this species to
carbapenems. The presence of the cftA gene, coding the production of this
enzyme. hes been detected by PCR among earbapenem-resisrant and
susceptible strains in different parrs of Europe. The expression of the cfiA
gene was found to be connected with the presence ofIS element•. Decreased
